Fundraising Fox

Sushmita M. Chanda

Executive Vice President, Chief Development Officer at Aligos Therapeutics

United States

Find your path to Sushmita

154 people in our graph share verified history with Sushmita — schools, employers, funds. One of them is your warm intro.

Mike FitzgeraldunlockedSushmita: together at Roche Palo Alto (2001–2005)
×9Sushmita: together at Roche Palo Alto
Sushmita: together at Aligos Therapeutics
Sushmita: together at The University of North Carolina at Chapel Hill

Executive Vice President, Chief Development Officer at Aligos Therapeutics

Intro paths

→

In turn, Sushmita can intro founders to Aligos Therapeutics's investors below.

Aligos Therapeutics's investors · 3

MPM BioVentures 2014Cambridge · since 2023Roche Venture FundBasel · $648K – $3.2M checksVivo CapitalPalo Alto · $10M – $50M checks · since 2019

Co-founders at Aligos Therapeutics

LB
Leonid BeigelmanPresident
LMLawrence M. Blatt
Lawrence M. BlattChairman, President & CEO (Co-founder)

Experience

  1. Aligos TherapeuticsChief Development Officercurrent2024 — presentUnited States
  2. Aligos TherapeuticsEVP, Translational Safety Sciences2018 — 2024South San Franscisco
  3. Alios BioPharma, a Johnson and Johnson CompanyVP, Preclinical Development2010 — 2018
  4. Roche Palo AltoSr. Director, Head Non Clinical Safety2009 — 2010
  5. Roche Palo AltoDirector, Toxicology, Non Clinical Safety2000 — 2009
  6. Sugen IncToxicologist1998 — 2000

Skills & more

INDDrug DiscoveryToxicologyDrug DevelopmentPharmaceutical IndustryGLPNeuroscienceGCPDMPKProtein ChemistryLifesciencesOncology
+12 moreInfectious DiseasesCROBiomarkersRegulatory SubmissionsBiopharmaceuticalsClinical DevelopmentAssay DevelopmentTechnology TransferMedicinal ChemistryClinical TrialsBiologicsFDA
  • Diplomate of the American Board of Toxicology — American Board of Toxicology, Inc.

From Sushmita's professional profile.

Frequently asked questions

Who is Sushmita M. Chanda?
Executive Vice President, Chief Development Officer at Aligos Therapeutics
Where does Sushmita M. Chanda work?
Sushmita M. Chanda is Executive Vice President, Chief Development Officer at Aligos Therapeutics.
Where did Sushmita M. Chanda go to school?
Sushmita M. Chanda studied at The University of North Carolina at Chapel Hill (Post Doctoral Training, Toxicology); University of Louisiana Monroe (Ph.D., Toxicology and Pharmacology).

Same school

Also attended The University of North Carolina at Chapel Hill492

Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionEric WagnerVP of Research and Data at Redpoint VenturesSoul DayanInvestor at True VenturesAlex LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED Investors

+ 486 more

Also attended University of Louisiana Monroe2

John ForrestFounder at VeravasMarcus IhlenfeldFounder at Woom

Shared employers

Also worked at Aligos Therapeutics9

Bridget Martell MA, MDSenior Biopharmaceutical Advisor at Two Bear CapitalJack NielsenManaging Partner at Vivo CapitalPierre RaboissonChief Executive Officer Chief Scientific Officer Co-founder at CoultreonFrançois GonzalvezCo-founder at CoultreonSandrine VendevilleCo-founder at CoultreonHardean AchneckExecutive Officer at Aligos Therapeutics

+ 3 more

Also worked at Roche Palo Alto229

Joe HorsmanInvestor at Madrona Venture GroupMarco PrunottoInvestor at MedicxiMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersCyndi ReseburgInvestor at Initialized Capital

+ 223 more

Also worked at Sugen Inc1

Danielle Olander-MoghadassianConsulting Chief Human Resources Officer at CytomX